eISSN: 2345-2781  
Submitted: 10 Oct 2017

Accepted: 02 Jan 2018
First published online: 19 Jan 2018
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

Abstract Page Views: 332
PDF Downloads: 159
Full Text Views: 0
J Renal Inj Prev. 2018;7(3):124-128.
doi: 10.15171/jrip.2018.30

Original Article

Chronic kidney disease among the Iranian-Azari population; a report from pilot phase of AZAR cohort study

Fariba Mahmoodpoor 1, Mohammad-Reza Ardalan 1 * , Mohammadhossein Somi 2, Elnaz Faramarzi 2, Sepideh Zununi Vahed 1, Mousa Ghaoyr Nahand 1

1 Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
*Corresponding author: Prof. Mohammad-Reza Ardalan, Email; Email: ardalan34@yahoo.com

Abstract

Introduction: Chronic kidney disease (CKD) is a worldwide health problem. Most patients with CKD are asymptomatic and unaware of their disease until reaches its latter stages. The worldwide prevalence of CKD is increasing and delayed diagnosis takes from the patients the opportunities for early treatment. Objectives: Our cohort, named AZAR cohort, is a part of a national cohort program and it is aimed to study the major cardiovascular, pulmonary, renal, diabetes, and cancers diseases risk factors in East-Azerbaijan province in North West of Iran.

Patients and Methods: In this cross-sectional study, all eligible subjects (35-65 years) were recruited. Information about demographic, medical history, some physical and para-clinical were collected. Here, we report the results of pilot phase of this study.

Results: Findings showed that prevalence of CKD (stage 3, eGFR<60 mL/min) among our studied population was 8% (71/898). The studied population was ranged from young adult to pre-elderly (35-65 years). We found a higher proportion of CKD in women (M/F 14/57). The total proportion of diabetics in our study was 126 persons (14%). Distribution of different stages of CKD was as follows: stage 3A (67 persons, M/F; 14/53), stage 3B (4 females), stage 2 (737 persons, M/F; 328/409) and stage 1 (88 persons, M/F; 64/24). There were no cases of CKD stage 4 or 5 in our cohort. Body mass index (BMI), serum triglyceride (TG), and cholesterol levels had a significant correlation with CKD stage 3 (P<0.05). Diabetic patients and female gender were at increased risk of CKD stage 3 (OR: 1.5; 95% CI: 0.857-2.861).

Conclusion: The prevalence of CKD stage 3 in our cohort was compatible with other previous publications. The higher prevalence of CKD in middle aged to early elderly women population could be explained by the high prevalence of obesity among this population.

Implication for health policy/practice/research/medical education:

Early diagnosis and implementation of simple preventive measurements are the key elements to fight against the risk of CKD. In this regard awareness about the prevalence of CKD and its probable risk factors are the first steps toward those goals.

Please cite this paper as: Mahmoodpoor F, Ardalan MR, Somi M, Faramarzi E, Zununi Vahed S, Ghaoyr Nahand M. Chronic kidney disease among the Iranian-Azari population; a report from pilot phase of AZAR cohort study. J Renal Inj Prev. 2018;7(3):124-128. doi: 10.15171/jrip.2018.30.

First name
 
Last name
 
Email address
 
Comments
 
Security code